Pfizer says it will end global development of gene therapy Beqvez, Nikkei reports-March 2024-www.financetom.com

Pfizer says it will end global development of gene therapy Beqvez, Nikkei reports

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Pfizer says it will end global development of gene therapy Beqvez, Nikkei reports

Feb 20, 2025 12:10 PM

Feb 20 (Reuters) - Pfizer ( PFE ) will end global

development of its bleeding disorder gene therapy, Beqvez, the

Nikkei reported on Thursday.

Beqvez was approved in the U.S. last year, for the treatment

of adults with moderate to severe hemophilia B.

Previous page： JSPL to spend Rs 2000 crore for getting newly aquired Angul plant from Monnet Power on stream Next page： Manappuram Finance sees increasing demand for credit from the bottom of the pyramid

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

JSPL to spend Rs 2000 crore for getting newly aquired Angul plant from Monnet Power on stream

Dec 14, 2022

JSPL confirmed that it will be purchasing Monnet Power's Angul plant for Rs 410 crore. The company earlier had said that the Angul unit's capacity is at 1,050 megawatt (MW) and it will ensure cheaper power for JSPL.

Manappuram Finance sees increasing demand for credit from the bottom of the pyramid

Dec 14, 2022

Manappuram Finance is expecting to meet its growth target as its gold as well as non-gold portfolios are seeing rising demand from the bottom of the pyramid.

Reliance Infra-Delhi Metro case: SC gives high court 3 months to resolve Rs 4,500 crore dues issue

Dec 14, 2022

The top court noted that the law for executing arbitral awards is not different for government or government-controlled entities. It maintained that the Delhi HC has been adjourning proceedings from time to time and directed the High court to take the issue to "logical conclusion".

The newly listed Fusion Microfinance has made a 21% gain for its IPO investors in the first month

Dec 14, 2022

The newly listed Fusion Micro Finance stock has been on a tear. It has seen a 21 percent upmove ever since November 15 when it debuted on the bourses.